We are a leading technological service of the National Council for Scienti c Research of Argentina born at the Cardiovascular Pathology Laboratory of Biomedical Research Institute at Catholic University of Argentina .
We focus on cardiovascular health and that compels us to investigate, understand, and generate outstanding knowledge of high impact for cardiovascular health.
We innovate by investigate new treatments, drugs, and therapies in preclinical models of cardiovascular pathology.
With the support of CONICET, at the heart of UCA and with our own equipment, at Beating Science we bring our extensive professional experience and knowledge to find the mechanisms related to the onset, development, evolution, and treatment of the leading cause of death worldwide: cardiovascular diseases.
We constantly investigate new mechanisms using efficient protocols that improve data generation and reduce the cost of implementing a research protocol for drugs and medical devices under development, giving rise to new therapeutic approaches for cardiovascular pathology and hypertension.
Investigating each beating heart heartbeat.
We are available to biopharmaceutical companies, government agencies, medical teams, healthcare providers, hospitals, health systems, and research organizations.
We palpitate with every possibility of discovering solutions and we commit to achieving the research and development goals of each client's critical projects. Working together, bringing science, innovation, and heart.
Dr. Germán González Director, scientific investigator CONICET Mail: germangonzalez@uca.edu.ar
SERVICES
At Beating Science, we develop in vivo and in vitro protocols and experimental studies that reproduce cardiovascular pathologies to identify the effect of drugs and devices on them. We provide advice on protocols for investigating new drugs and aim to discover novel drug mechanisms of action. We conduct in vivo and in vitro studies as well as histopathological, molecular biology, metabolic, and functional analyses with the precision and scientific rigor that your project's health requires.
Research and Development
- Consulting and advice to research groups and pharmaceutical companies for the design, development, and execution of preclinical and/or experimental studies to test pharmaceutical compounds and drugs for several therapeutic uses.
- Design and implementation of highly complex biological tests for research and development.
- Development & Design of preclinical trials for national and international regulatory agencies.
- Biochemical, pharmacological, toxicological, histopathological, immunological studies.
- Experimental surgeries.
– In vivo and in vitro assays.
– Implementation, quantification, analysis, and interpretation of ventricular function studies by catheterization and bi-dimensional echocardiography, and color Doppler.
EQUIPMENT
- Design and perform of biological tests for research and development of new products.
- Undergraduate and postgraduate courses, or training on topics related to a wide variety of cardiovascular pathologies and experimental models that reproduce them.
Highly equipped surgical rooms with respirators for medium and small animals. High precision stereoscopic microscope, precision surgical instruments for performing experimental microsurgeries. Hemodynamic recording systems (Powerlab Ad instrument) for monitoring ventricular function and heart rate in real time.
Bi-dimensional echocardiograph and Doppler.
_ Monitoring and recording system for rodent blood pressure.
Metabolic cages for 24-hour urine sample collection.
Equipment for electrophoresis. Equipment for biochemical quantification of tissue collagen.
Elements for tissue processing immunohistochemistry and mimunofluorescence.
Photomicroscope and image analyzer system.
Facilities of the BIOMED Institute
◦ Central animal facility.
◦ Processing of histological samples.
◦ Culture rooms.
